In branch retinal vein occlusion (BRVO), abnormal arteriovenous crossing with vein compression, degenerative changes of the vessel wall and abnormal hematological factors constitute the primary mechanism of vessel occlusion. In general, BRVO has a good prognosis: 50-60% of eyes are reported to have a final visual acuity (VA) of 20/40 or better even without treatment. One important prognostic factor for final VA appears to be the initial VA. Grid laser photocoagulation is an established treatment for macular edema in a particular group of patients with BRVO, while promising results for this condition are shown by intravitreal application of steroids or new vascular endothelial growth factor inhibitors. Vitrectomy with or without arteriovenous sheathotomy combined with removal of the internal limiting membrane may improve vision in eyes with macular edema which are unresponsive to or ineligible for laser treatment.

Department of Ophthalmology University Hospital Palacky University Olomouc Czech Republic

Zobrazit více v PubMed

Klein R, Klein BE, Moss SE, Meuer SM. The epidemiology of retinal vein occlusion: The Beaver Dam Eye Study. Trans Am Ophthalmol Soc. 2000;98:133–141. PubMed PMC

Mitchell P, Smith W, Chang A. Prevalence and associations of retinal vein occlusion in Australia. The Blue Mountains Eye Study. Arch Ophthalmol. 1996;114:1243–1247. PubMed

David R, Zangwill L, Badarna M, Yassur Y. Epidemiology of retinal vein occlusion and its association with glaucoma and increased intraocular pressure. Ophthalmologica. 1988;197:69–74. PubMed

Hayreh SS, Zimmerman B, Podhajsky P. Incidence of various types of retinal vein occlusion and their recurrence and demographic characteristics. Am J Ophthalmol. 1990;117:429–441. PubMed

Leber T. Graefe-Saemisch. Handbuch der Gesamten Augenheikunde. Leipzig: Verlag von Wilhelm Engelmann; 1877. Die Krankheite der Netzhaut und des Sehnerven; p. 531.

Glacet-Bernard A, Coscas G, Chabanel A, Zourdani A, Lelong F, Samama MM. Prognostic factors for retinal vein occlusion: Prospective study of 175 cases. Ophthalmology. 1996;103:551–560. PubMed

Appiah AP, Trempe CL. Risk factors associated with branch vs. central retinal vein occlusion. Ann Ophthalmol. 1989;21:153–157. PubMed

Rath EZ, Frank RN, Shin DH, Kim C. Risk factors for retinal vein occlusions. A case-control study. Ophthalmology. 1992;99:509–514. PubMed

Lang GE, Freissler K. Clinical and fluorescein angiography findings in patients with retinal vein occlusion. A unicenter study of 211 patients. Klin Monatsbl Augenheilkd. 1992;201:234–239. PubMed

Orth DH, Patz A. Retinal branch vein occlusion. Surv Ophthalmol. 1978;22:357–380. PubMed

Koyanagi Y. The role of arteriovenous crossing for occuring of retinal branch vein occlusion. Klin Monatsbl Augenheilkd. 1928;81:219–231.

Zhao J, Sastry SM, Sperduto RD, Chew EY, Remaley NA. Arteriovenous crossing patterns in branch retinal vein occlusion. Ophthalmology. 1993;100:423–428. PubMed

Duker JS, Brown GC. Anterior location of the crossing artery in branch retinal vein obstruction. Arch Ophthalmol. 1989;107:998–1000. PubMed

Jefferies P, Clemett R, Day T. An anatomical study of retinal arteriovenous crossings and their role in the pathogenesis of retinal branch vein occlusions. AustNZJ Ophthalmol. 1993;21:213–217. PubMed

Seitz R. The Retinal Vessels: Comparative Ophthalmoscopic and Histologic Studies on Healthy and Diseased Eyes. St. Louis, MO: CV Mosby; 1964. p. 28.

Frangieh GT, Green WR, Barraquer-Somers E, Finkelstein D. Histopathologic study of branch retinal vein occlusion. Arch Ophthalmol. 1982;100:1132–1140. PubMed

Christoffersen NL, Larsen M. Pathophysiology and hemodynamic of branch retinal vein occlusion. Ophthalmology. 1999;106:2054–2062. PubMed

Trope GE, Lowe GD, McArdle BM, Douglas JT, Forbes CD, Prentice CM, Foulds WS. Abnormal blood viscosity and haemostasis in long-standing retinal vein occlusion. Br J Ophthalmol. 1983;67:137–142. PubMed PMC

McGrath MA, Wechsler F, Hunyor AB, Penny R. Systemic factors contributory to retinal vein occlusion. Arch Intern Med. 1978;138:216–220. PubMed

Chen HC, Wiek J, Gupta A, Luckie A, Kohner EM. Effect of isovolaemic haemodilution on visual outcome in branch retinal vein occlusion. Br J Ophthalmol. 1998;82:162–167. PubMed PMC

Janssen MCH, de Heijer M, Cruysberg JRM, Wollersheim H, Bredie SJH. Retinal vein occlusion: A form of venous thrombosis or a complication of atherosclerosis? Thromb Haemost. 2005;93:1021–1026. PubMed

Clouse LH, Comp PC. The regulation of hemostasis: The protein C system. N Eng J Med. 1986;314:1298–1304. PubMed

Tekeli O, Gürsel E, Buyurgan H. Protein C, protein S and antithrombin III deficiencies in retinal vein occlusion. Acta Ophthlamol Scand. 1999;77:628–630. PubMed

Bombeli T, Basic A, Fehr J. Prevalence of hereditary thrombophilia in patients with thrombosis in different venous systems. Am J Hematol. 2002;70:126–132. PubMed

Glueck CJ, Wang P, Bell H, Rangaraj V, Goldenberg N. Associations of thrombophilia, hypofibrinolysis, and retinal vein occlusion. Clin Appl Thromb Hemost. 2005;11:375–389. PubMed

Marcucci R, Bertini L, Giusti B, Brunelli T, Fedi S, Cellai AP, Poli D, Pepe G, Abbate R, Prisco D. Thrombophilic risk factors in patients with central retinal vein occlusion. Thromb Haemost. 2001;86:772–776. PubMed

Dahlbäck B, Carlsson M, Svensson PJ. Familiar thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: Predilection of a cofactor to activated protein C. Proc Natl Acad Sci USA. 1993;90:1004–1008. PubMed PMC

Dahlbäck B. Physiological anticoagulation: Resistance to activated protein C and venous thromboembolism. J Clin Invest. 1994;94:923–927. PubMed PMC

Bertina RM, Koeleman BPC, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, van der Velden PA, Reitsma PH. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature. 1994;369:64–67. PubMed

Greiner K, Peetz D, Winkgen A, Prellwitz W, Pfeiffer N, Hafner G. Genetic thrombophilia in patients with retinal vascular occlusion. Int Ophthalmol. 1999;23:155–160. PubMed

Larsson J, Sellman A, Bauer B. Activated protein C resistance in patients with central retinal vein occlusion. Br J Ophthalmol. 1997;81:832–834. PubMed PMC

Larsson J, Hillarp A, Olafsdottir E, Bauer B. Activated protein C resistance and anticoagulant proteins in young adults with central retinal vein occlusion. Acta Ophthalmol Scand. 1999;77:634–637. PubMed

Kuhli C, Hattenbach LO, Scharrer I, Koch F, Ohrloff Ch. High prevalence of resistance to APC in young patients with retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol. 2002;240:163–168. PubMed

Arssene S, Delahousse B, Regina S, Le Lez ML, Pisella PJ, Gruel Y. Increased prevalence of factor V Leiden in patients with retinal vein occlusion and under 60 years of age. Thromb Haemost. 2005;94:101–106. PubMed

Gottlieb JL, Blice JP, Mestichelli B, Konkle BA, Benson WE. Activated protein C resistance, factor V Leiden, and central retinal vein occlusion in young adults. Arch Ophthalmol. 1998;116:577–579. PubMed

Demirci FYK, Güney DB, Akarcay K, Kir N, Özbek U, Sirma S, Ünaltuna N, Öngör E. Prevalence of factor V Leiden in patients with retinal vein occlusion. Acta Ophthalmol Scand. 1999;77:631–633. PubMed

Ates O. The deficiencies of protein C, protein S and antithrombin III in patients with retinal vein occlusion: A Turkish sample. Clin Lab Haematol. 2006;28:391–392. PubMed

Adamzuk YP, Iglesias Varela ML, Martinuzzo ME, Cerrato GS, Forastiero RR. Central retinal vein occlusion and thrombophilia risk factors. Blood Coagul Fibrinolysis. 2002;13:623–626. PubMed

Larsson J, Hillarp A. The prothrombin gene G20210A mutation and the platelet glycoprotein IIIa polymorphism PlA2 in patients with central retinal vein occlusion. Thromb Res. 1999;96:323–327. PubMed

Kalayci D, Gurgey A, Guven D, Parlak H, Hasiripi H. Factor V Leiden and prothrombin 20210 A mutations in patients with central and branch retinal vein occlusion. Acta Ophthalmol Scand. 1999;77:622–624. PubMed

Wahl DG, Guillemin F, de Maistre E, Perret-Guillaume C, Lecompte T, Thibaut G. Meta-analysis of the risk of venous thrombosis in individuals with antiphospholipid antibodies without underlying autoimmune disease or previous thrombosis. Lupus. 1998;7:15–22. PubMed

Clarke R, Daly L, Robinson K, Naughten E, Cahalane S, Fowler B, Graham I. Hyperhomocysteinemia: An independent risk factor for vascular disease. N Engl J Med. 1991;324:1149–1155. PubMed

Welch GN, Loscalzo J. Homocysteine and atherothrombosis. N Engl J Med. 1998;338:1142–1150. PubMed

Cahill MT, Stinnett SS, Fekrat S. Meta-analysis of plasma homocysteine, serum folate, serum vitamin B12, and thermolabile MTHFR genotype as risk factors for retinal vascular occlusive disease. Am J Ophthalmol. 2003;136:1136–1150. PubMed

Loewenstein A, Goldstein M, Winder A, Lazar M, Eldor A. Retinal vein occlusion associated with methylenetetrahydrofolate reductase mutation. Ophthalmology. 1999;106:1817–1820. PubMed

Cahill M, Karabatzaki M, Donoghue C, Meleady R, Mynett-Johnson LA, Mooney D, Graham IM, Whitehead AS, Shields DC. Thermolabile MTHFR genotype and retinal vascular occlusive disease. Br J Ophthalmol. 2001;85:88–90. PubMed PMC

Arnarsson A, Stefansson E. Laser treatment and the mechanism of edema reduction in branch retinal vein occlusion. Invest Ophthalmol Vis Sci. 2000;41:877–879. PubMed

Stefansson E. The therapeutic effects of retinal laser treatment and vitrectomy. A theory based on oxygen and vascular physiology. Acta Ophthalmol Scand. 2001;79:435–440. PubMed

Silva RM, Faria de Abreu JR, Cunha-Vaz JG. Blood-retina barrier in acute retinal branch vein occlusion. Graefes Arch Clin Exp Ophthalmol. 1995;233:721–726. PubMed

Saika S, Tanaka T, Miyamoto T, Ohnishi Y. Surgical posterior vitreous detachment combined with gas/air tamponade for treating macular edema associated with branch retinal vein occlusion: Retinal tomography and visual outcome. Graefes Arch Clin Exp Ophthalmol. 2001;239:729–732. PubMed

Aiello LP, Avery RL, Arrigg PG, Keyt BA, Jampel HD, Shah ST, Pasquale LR, Thieme H, Iwamoto MA, Park JE. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med. 1994;331:1480–1487. PubMed

Noma H, Minamoto A, Funatsu H, Tsukamoto H, Nakano K, Yamashita H, Mishima HK. Intravitreal levels of vascular endothelial growth factor and interleukin-6 are correlated with macular edema in branch retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol. 2006;244:309–315. PubMed

Wetzig PC. The treatment of acute branch vein occlusion by photocoagulation. Am J Ophthalmol. 1979;87:65–73. PubMed

Branch Vein Occlusion Study Group. Argon laser scatter photocoagulation for prevention of neovascularization and hemorrhage in branch vein occlusion. Arch Ophthalmol. 1986;104:34–41. PubMed

Tsaloumas MD, Kirwan J, Vinall H, O'Leary MB, Prior P, Kritzinger EE, Dodson PM. Nine year follow-up study of morbidity and mortality in retinal vein occlusion. Eye. 2000;14:821–827. PubMed

Gutman FA, Zegarra H, Zakov ZN. The natural course of temporal retinal vein occlusion. Trans Am Acad Opthalmol Otolaryngol. 1974;78:178–192. PubMed

Hayreh SS, Rojas P, Podhajsky P, Montague P, Woolson RF. Ocular neovascularization with retinal occlusion: III. Incidence of neovascularization with retinal vascular occlusion. Ophthalmology. 1983;90:488–506. PubMed

Magargal LE, Sanborn GE, Kimmel AS, Annesley WH. Temporal branch retinal vein obstruction: A review. Ophthal Surg. 1986;17:240–246. PubMed

Michels RG, Gass JDM. Natural course of temporal retinal branch occlusion. Trans Am Acad Ophthalmol Otolaryngol. 1974;78:166–177. PubMed

Gutman FA. Macular edema in branch retinal vein occlusion: Prognosis and management. Trans Am Acad Ophthalmol Otolaryngol. 1977;83:488–493. PubMed

Finkelstein D. Argon laser photocoagulation for macular edema in branch vein occlusion. Ophthalmology. 1986;93:975–977. PubMed

Shilling JS, Jones CA. Retinal branch vein occlusion: A study of argon laser photocoagulation in the treatment of macular oedema. Br J Ophthalmol. 1984;68:196–198. PubMed PMC

Finkelstein D. Ischemic macular edema: Recognition and favorable natural history in branch vein occlusion. Arch Ophthalmol. 1992;110:1427–1434. PubMed

Jalkh AE, Avila PM, Zakka KA, Trempe CL, Schepens CS. Chronic macular edema in retinal branch vein occlusion: Role of laser photocoagulation. Annals Ophthalmol. 1984;16:526–533. PubMed

Subramanian ML, Heier JS, Esrick E, Devaiah AK, Topping TM, Frederick AR, Morley MG. Preoperative visual acuity as a prognostic indicator for laser treatment of macular edema due to branch retinal vein occlusion. Ophthalmic Surg Lasers Imaging. 2006;37:462–467. PubMed

Lang GE, Händel A. Results of laser coagulation of retinal branch vein occlusion. Klin Monatsbl Augenheilkd. 1993;203:180–188. PubMed

Weiss JN, Bynoe LA. Injection of tissue plasminogen activator into a branch retinal vein in eyes with central retinal vein occlusion. Ophthalmology. 2001;108:2249–2257. PubMed

Houtsmuller AJ, Vermeulen JA, Klompe M, Zahn KJ, Henkes HE, Baarsma GS, Tijssen J. The influence of ticlopidine on the natural course of retinal vein occlusion. Agents Actions Suppl. 1984;15:219–229. PubMed

Glacet-Bernard A, Coscas G, Chabanel A, et al. A randomized, double-masked study on the treatment of retinal vein occlusion with troxerutin. Am J Ophthalmol. 1994;118:421–429. PubMed

Hulse JD, Yacobi A. Hetastarch: An overview of the colloid and its metabolism. Drug Intell Clin Pharm. 1983;17:334–341. PubMed

Waters LM, Christensen MA, Sato RM. Hetastarch: An alternative colloid in burn shock management. J Burn Care Rehab. 1989;1:11–16. PubMed

Poupard P, Eledjam JJ, Dupeyron G, et al. Role of acute normovolemic hemodilution in treating retinal venous occlusions. Ann Fr Anesth Reanim. 1986;5:229–233. PubMed

Hansen LL, Wiek J, Arntz R. Randomized study of the effect of isovolemic hemodilution in retinal branch vein occlusion. Fortschr Ophthalmol. 1988;85:514–516. PubMed

Janvrin SB, Davies G, Greenhalgh RM. Postoperative deep vein thrombosis, an association with haemodilution. Br J Surg. 1980;67:690–693. PubMed

Osterloh MD, Charles S. Surgical decompression of branch retinal vein occlusions. Arch Ophthalmol. 1988;106:1469–1471. PubMed

Garcia-Arumi J, Martinez-Castillo V, Boixadera A, Blasco H, Corcostegui B. Management of macular oedema in branch retinal vein occlusion with sheathotomy and recombinant tissue plasminogen activator. Retina. 2004;24:530–540. PubMed

Yamamoto S, Saito W, Yagi F, Takeuchi S, Sato E, Mizunoya S. Vitrectomy with or without arteriovenous adventitial sheathotomy for macular edema associated with branch retinal vein occlusion. Am J Ophthalmol. 2004;138:907–914. PubMed

Charbonnel J, Glacet-Bernard A, Korobelnik J, et al. Management of branch retinal vein occlusion with vitrectomy and arteriovenous adventitial sheathotomy, the possible role of surgical posterior vitreous detachment. Graefes Arch Clin Exp Ophthalmol. 2004;242:223–228. PubMed

Sohn JH, Song SJ. Arteriovenous sheathotomy for persistent macular edema in branch retinal vein occlusion. Korean J Ophthalmol. 2006;20:210–214. PubMed PMC

Kumagai K, Furukawa M, Ogino N, Uemura A, Larson E. Long-term outcomes of vitrectomy with or without arteriovenous sheathotomy in branch retinal vein occlusion. Retina. 2007;27:49–54. PubMed

Avci R, Inan U, Kaderli B. Evaluation of arteriovenous crossing sheathotomy for decompression of branch retinal vein occlusion. Eye. 2008;22:120–127. PubMed

Horio N, Horiguchi M. Effect of arteriovenous sheathotomy on retinal blood flow and macular edema in patients with branch retinal vein occlusion. Am J Ophthalmol. 2005;139:739–740. PubMed

Lakhanpal RR, Javaheri M, Ruiz-Garcia H, De Juan E, Jr, Humayun MS. Transvitreal limited arteriovenous-crossing manipulation without vitrectomy for complicated branch retinal vein occlusion using 25-gauge instrumentation. Retina. 2005;25:272–280. PubMed

Mester U, Dillinger P. Vitrectomy with arteriovenous decompression and internal limiting membrane dissection in branch retinal vein occlusion. Retina. 2002;22:740–746. PubMed

Opremcak EM, Bruce RA. Surgical decompression of branch retinal vein occlusion via arteriovenous crossing sheathotomy: A prospective review of 15 cases. Retina. 1999;19:1–5. PubMed

Asensio Sanchez VM, Rodriguez Bravo I, Botella Oltra G. Adventitial sheathotomy in branch retinal vein occlusion with nonischemic macular edema. Arch Soc Esp Oftalmol. 2004;79:347–352. PubMed

Lerche RC, Richard G. Arteriovenous sheathotomy in venous thrombosis. Klin Monatsbl Augenheilkd. 2004;221:479–484. PubMed

Mason J, Feist R, White M, Jr, Swanner J, McGwin G, Jr, Emond T. Sheathotomy to decompress branch retinal vein occlusion: A matched control study. Ophthalmology. 2004;111:540–545. PubMed

Cahill MT, Kaiser PK, Sears JE, et al. The effect of arteriovenous sheathotomy on cystoid macular oedema secondary to branch retinal vein occlusion. Br J Ophthalmol. 2003;87:1329–1332. PubMed PMC

Becquet F, Le Rouic JF, Zanlonghi X, Peronnet P, Hermouet-Leclair E, Pousset-Decre C, Ducournau D. Efficiency of surgical treatment for chronic macular edema due to branch retinal vein occlusion. J Fr Ophtalmol. 2003;26:570–576. PubMed

Martinez-Soroa I, Ruiz Miguel M, Ostolaza JI, Perez-Torres S, Mendicute J. Surgical arteriovenous decompression (sheathotomy) in branch retinal vein occlusion: Retrospective study. Arch Soc Esp Oftalmol. 2003;78:603–608. PubMed

Le Rouic JF, Bejjani RA, Rumen F, Caudron C, Bettembourg O, Re-nard G, Chauvaud D. Adventitial sheathotomy for decompression of recent onset branch retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol. 2001;239:747–751. PubMed

Dotrelova D, Dubska Z, Kuthan P, Stepankova J. Initial experience with surgical decompression of the vein in branch retinal vein occlusion. Cesk Slov Oftalmol. 2001;57:359–366. PubMed

Shah GK, Sharma S, Fineman MS. Arteriovenous adventitial sheathotomy for the treatment of macular oedema associated with branch retinal vein occlusion. Am J Ophthalmol. 2000;129:104–106. PubMed

Crafoord S, Karlsson N, la Cour M. Sheathotomy in complicated cases of branch retinal vein occlusion. Acta Ophthalmol Scand. 2007 Aug 17; Epub ahead of print. PubMed

Han DP, Bennett SR, Williams DF, Dev S. Arteriovenous crossing dissection without separation of the retina vessels for treatment of branch retinal vein occlusion. Retina. 2003;23:145–151. PubMed

Mandelcorn MS, Nrusimhadevara RK. Internal limiting membrane peeling for decompression of macular edema in retinal vein occlusion: A report of 14 cases. Retina. 2004;24:348–355. PubMed

Mandelcorn MS, Mandelcorn E, Guan K, Adatia FA. Surgical macular decompression for macular edema in retinal vein occlusion. Can J Ophthalmol. 2007;42:116–122. PubMed

Avitabile T, Longo A, Reibaldi A. Intravitreal triamcinolone compared with macular laser grid photocoagulation for the treatment of cystoid macular edema. Am J Ophthalmol. 2005;140:695–702. PubMed

Oh JY, Seo JH, Ahn JK, Heo JW, Chung H. Early versus late intravitreal triamcinolone acetonide for macular edema associated with branch retinal vein occlusion. Korean J Ophthalmol. 2007;21:18–20. PubMed PMC

Ozkiris A, Evereklioglu C, Erkilic K, Dogan H. Intravitreal triamcinolone acetonide for treatment of persistent macular edema in branch retinal vein occlusion. Eye. 2006;20:13–17. PubMed

Jonas JB, Akkoyun I, Kamppeter B, Kreissig I, Degenring RF. Branch retinal vein occlusion treated by intravitreal triamcinolone acetonide. Eye. 2005;19:65–71. PubMed

Cekic O, Chang S, Tseng JJ, Barile GR, Del Priore LV, Weissman H, Schiff WM, Ober MD. Intravitreal triamcinolone injection for treatment of macular edema secondary to branch retinal vein occlusion. Retina. 2005;25:851–855. PubMed

Lee H, Shah GK. Intravitreal triamcinolone as primary treatment of cystoid macular edema secondary to branch retinal vein occlusion. Retina. 2005;25:551–555. PubMed

Ozkiris A, Evereklioglu C, Erkiliç K, Ilhan O. The efficacy of intravitreal triamcinolone acetonide on macular edema in branch retinal vein occlusion. Eur J Ophthalmol. 2005;15:96–101. PubMed

Yepremyan M, Wertz FD, Tivnan T, Eversman L, Marx JL. Early treatment of cystoid macular edema secondary to branch retinal vein occlusion with intravitreal triamcinolone acetonide. Ophthalmic Surg Lasers Imaging. 2005;36:30–36. PubMed

Cheng KC, Wu WC. Intravitreal triamcinolone acetonide for patients with macular edema due to branch retinal vein occlusion. Kaohsiung J Med Sci. 2006;22:321–330. PubMed PMC

Chen SD, Lochhead J, Patel CK, Frith P. Intravitreal triamcinolone acetonide for ischaemic macular oedema caused by branch retinal vein occlusion. Br J Ophthalmol. 2004;88:154–155. PubMed PMC

Chen SD, Sundaram V, Lochhead J, Patel CK. Intravitreal triamcinolone for the treatment of ischemic macular edema associated with branch retinal vein occlusion. Am J Ophthalmol. 2006;141:876–883. PubMed

Tsujikawa A, Fujihara M, Iwawaki T, Yamamoto K, Kurimoto Y. Triamcinolone acetonide with vitrectomy for treatment of macular edema associated with branch retinal vein occlusion. Retina. 2005;25:861–867. PubMed

Karacorlu M, Ozdemir H, Karacorlu SA. Resolution of serous macular detachment after intravitreal triamcinolone acetonide treatment of patients with branch retinal vein occlusion. Retina. 2005;25:856–860. PubMed

Krepler K, Ergun E, Sacu S, Richter-Muksch S, Wagner J, Stur M, Wedrich A. Intravitreal triamcinolone acetonide in patients with macular oedema due to branch retinal vein occlusion: A pilot study. Acta Ophthalmol Scand. 2005;83:600–604. PubMed

Degenring RF, Kamppeter B, Kreissig I, Jonas JB. Morphological and functional changes after intravitreal triamcinolone acetonide for retinal vein occlusion. Acta Ophthalmol Scand. 2003;81:399–401. PubMed

Wakabayashi T, Okada AA, Morimura Y, Kojima E, Asano Y, Hirakata A, Hida T. Trans-tenon retrobulbar triamcinolone infusion for chronic macular edema in central and branch retinal vein occlusion. Retina. 2004;24:964–967. PubMed

Salinas-Alamán A, García-Layana A, Sádaba-Echarri LM, Belzunce-Manterola A. Branch retinal vein occlusion treated by intravitreal triamcinolone. Arch Soc Esp Oftalmol. 2005;80:463–465. PubMed

Hirano Y, Sakurai E, Yoshida M, Ogura Y. Comparative study on efficacy of a combination therapy of triamcinolone acetonide administration with and without vitrectomy for macular edema associated with branch retinal vein occlusion. Ophthalmic Res. 2007;39:207–212. PubMed

Kuppermann BD, Blumenkranz MS, Haller JA, Williams GA, Weinberg DV, Chou C, Whitcup SM, Dexamethasone DDS Phase II Study Group Randomized controlled study of an intravitreous dexamethasone drug delivery system in patients with persistent macular edema. Arch Ophthalmol. 2007;125:309–317. PubMed

Jonas JB, Degenring RF, Kreissig I, Akkoyun I, Kamppeter BA. Intraocular pressure elevation after intravitreal triamcinolone acetonide injection. Ophthalmology. 2005;112:593–598. PubMed

Jonas JB, Degenring RF, Kreissig I, Akkoyun I. Safety of intravitreal high-dose reinjections of triamcinolone acetonide. Am J Ophthalmol. 2004;138:1054–1055. PubMed

Scott IU, Flynn HW., Jr Reducing the risk of endophthalmitis following intravitreal injections. Retina. 2007;27:10–12. PubMed

Bhavsar AR, Ip MS, Glassman AR, DRCRnet and the SCORE Study Groups The risk of endophthalmitis following intravitreal triamcinolone injection in the DRCRnet and SCORE clinical trials. Am J Ophthalmol. 2007;144:454–456. PubMed PMC

Kawaji T, Hirata A, Awai N, Takano A, Inomata Y, Fukushima M, Tanihara H. Trans-tenon retrobulbar triamcinolone injection for macular edema associated with branch retinal vein occlusion remaining after vitrectomy. Am J Ophthalmol. 2005;140:540–542. PubMed

Hayashi K, Hayashi H. Intravitreal versus retrobulbar injections of triamcinolone for macular edema associated with branch retinal vein occlusion. Am J Ophthalmol. 2005;139:972–982. PubMed

Rosenfeld PJ, Fung AE, Puliafito CA. Optical coherence tomography findings after an intravitreal injection of bevacizumab (Avastin) for macular edema from central retinal vein occlusion. Ophthalmic Surg Lasers Imaging. 2005;36:336–339. PubMed

Iturralde D, Spaide RF, Meyerle CB, et al. Intravitreal bevacizumab (Avastin) treatment of macular edema in central retinal vein occlusion: A short-term study. Retina. 2006;26:279–284. PubMed

Rabena MD, Pieramici DJ, Castellarin AA, Nasir MA, Avery RL. Intravitreal bevacizumab (Avastin) in the treatment of macular edema secondary to branch retinal vein occlusion. Retina. 2007;27:419–425. PubMed

Spandau U, Wickenhauser A, Rensch F, Jonas J. Intravitreal bevacizumab for branch retinal vein occlusion. Acta Ophthalmol Scand. 2007;85:118–119. PubMed

Matsumoto Y, Freund KB, Peiretti E, Cooney MJ, Ferrara DC, Yannuzzi LA. Rebound macular edema following bevacizumab (Avastin) therapy for retinal venous occlusive disease. Retina. 2007;27:426–431. PubMed

Campochiaro PA, Shah SM, Hafiz G, Quinlan E, Zimmer-Galler I, Nguyen QD, Do DV, Ying H, Sung JU. Ranibizumab for Macular Edema Due to Retinal Vein Occlusions. ARVO. 2007 May 7; PubMed

Jaissle GB, Ziemssen F, Petermeier K, Szurman P, Ladewig M, Gelisken F, Volker M, Holz FG, Bartz-Schmidt KU. Bevacizumab for treatment of macular edema secondary to retinal vein occlusion. Ophthalmologe. 2006;103:471–475. PubMed

Ahmadieh H, Moradian S, Malihi M. Rapid regression of extensive retinovitreal neovascularization secondary to branch retinal vein occlusion after a single intravitreal injection of bevacizumab. Int Ophthalmol. 2005;26:191–193. PubMed

Costa RA, Jorge R, Calucci D, Melo LA, Jr, Cardillo JA, Scott IU. Intravitreal bevacizumab (Avastin) for central and hemicentral retinal vein occlusions: IBeVO study. Retina. 2007;27:141–119. PubMed

Pai SA, Shetty R, Vijayan PB, Venkatasubramaniam G, Yadav NK, Shetty BK, Babu RB, Narayana KM. Clinical, anatomic, and electrophysiologic evaluation following intravitreal bevacizumab for macular edema in retinal vein occlusion. Am J Ophthalmol. 2007;143:601–606. PubMed

Schaal KB, Höh AE, Scheuerle A, Schütt F, Dithmar S. Bevacizumab for the treatment of macular edema secondary to retinal vein occlusion. Ophthalmologe. 2007;104:285–289. PubMed

Stahl A, Agostini H, Hansen LL, Feltgen N. Bevacizumab in retinal vein occlusion results of a prospective case series. Graefes Arch Clin Exp Ophthalmol. 2007;245:1429–1436. PubMed

Iliev ME, Domig D, Wolf-Schnurrbursch U, Wolf S, Sarra GM. Intravitreal bevacizumab (Avastin) in the treatment of neovascular glaucoma. Am J Ophthalmol. 2006;142:1054–1056. PubMed

Batioglu F, Astam N, Ozmert E. Rapid improvement of retinal and iris neovascularization after a single intravitreal bevacizumab injection in a patient with central retinal vein occlusion and neovascular glaucoma. Int Ophthalmol. 2007 Jul 4; Epub ahead of print. PubMed

Yazdani S, Hendi K, Pakravan M. Intravitreal bevacizumab (Avastin) injection for neovascular glaucoma. J Glaucoma. 2007;16:437–439. PubMed

Kahook MY, Schuman JS, Noecker RJ. Intravitreal bevacizumab in a patient with neovascular glaucoma. Ophthalmic Surg Lasers Imaging. 2006;37:144–146. PubMed

Grisanti S, Biester S, Peters S, Tatar O, Ziemssen F, Bartz-Schmidt KU, Tuebingen Bevacizumab Study Group Intracameral bevacizumab for iris rubeosis. Am J Ophthalmol. 2006;142:158–160. PubMed

Branch Vein Occlusion Study Group. Argon laser photocoagulation for macular edema in branch retinal vein occlusion. Am J Ophthalmol. 1984;98:271–282. PubMed

Parodi MB, Saviano S, Bergamini L, Ravalico G. Grid laser treatment of macular edema in macular branch retinal vein occlusion. Doc Ophthalmol. 1999;97:427–431. PubMed

Parodi MB, Saviano S, Ravalico G. Grid laser treatment in macular branch retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol. 1999;237:1024–1027. PubMed

Kremer I, Hartman B, Siegal R, Ben-Sira I. Static and kinetic perimetry results of krypton red laser treatment for macular edema complicating branch vein occlusion. Ann Ophthalmol. 1990;22:193–197. PubMed

Hayreh SS, Rubenstein L, Podhajsky P. Argon laser scatter photocoagulation in treatment of branch retinal vein occlusion. A prospective clinical trial. Ophthalmologica. 1993;206:1–14. PubMed

L'Esperance FA. Ocular Photocoagulation. A Stereoscopic Atlas. St. Louis, MO: CV Mosby; 1975. pp. 215–222.

Rehak J. Branch retinal vein occlusion. Part 2. Early treatment with argon laser. New approach. New Trends Ophtalmol. 1997;12:77–82.

Rehak J. Retinal vein occlusion. III. Arteriolar constriction. Cesk Oftalmol. 1993;49:151–154. PubMed

Rehak J, Vymazal M. Arteriolar constriction in the treatment of branch retinal vein occlusion-Initial experience. Cesk Oftalmol. 1993;49:155–159. PubMed

Erdol H, Akyol N. Arterial crimping in branch retinal vein occlusion with macular edema. Acta Ophthalmol Scand. 2000;78:456–459. PubMed

Risk factors for central and branch retinal vein occlusion: a meta-analysis of published clinical data